BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24399121)

  • 1. Role of phytotherapy associated with antibiotic prophylaxis in female patients with recurrent urinary tract infections.
    Frumenzio E; Maglia D; Salvini E; Giovannozzi S; Di Biase M; Bini V; Costantini E
    Arch Ital Urol Androl; 2013 Dec; 85(4):197-9. PubMed ID: 24399121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.
    Costantini E; Zucchi A; Salvini E; Cicalese A; Li Marzi V; Filocamo MT; Bini V; Lazzeri M
    Int Urogynecol J; 2014 Sep; 25(9):1173-8. PubMed ID: 24554302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections.
    Rafailidis PI; Polyzos KA; Sgouros K; Falagas ME
    Int J Antimicrob Agents; 2011 Apr; 37(4):283-90. PubMed ID: 21300527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
    Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y
    Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach.
    Cai T; Cocci A; Tiscione D; Puglisi M; Di Maida F; Malossini G; Verze P; Palmieri A; Mirone V; Bjerklund Johansen TE
    Arch Ital Urol Androl; 2018 Jun; 90(2):97-100. PubMed ID: 29974725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
    Cai T; Mazzoli S; Bechi A; Addonisio P; Mondaini N; Pagliai RC; Bartoletti R
    Int J Antimicrob Agents; 2009 Jun; 33(6):549-53. PubMed ID: 19181486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
    Busetto GM; Giovannone R; Ferro M; Tricarico S; Del Giudice F; Matei DV; De Cobelli O; Gentile V; De Berardinis E
    BMC Urol; 2014 Jul; 14():53. PubMed ID: 25038794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study.
    Rudenko N; Dorofeyev A
    Arzneimittelforschung; 2005; 55(7):420-7. PubMed ID: 16080282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent urinary tract infections.
    Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Piechota HJ; Naber KG
    Minerva Urol Nefrol; 2013 Mar; 65(1):9-20. PubMed ID: 23538307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic prophylaxis with prulifloxacin in women undergoing induced abortion: a randomized controlled trial].
    Caruso S; Di Mari L; Cacciatore A; Mammana G; Agnello C; Cianci A
    Minerva Ginecol; 2008 Feb; 60(1):1-5. PubMed ID: 18277346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method].
    Egrot C; Dinh A; Amarenco G; Bernard L; Birgand G; Bruyère F; Chartier-Kastler E; Cosson M; Deffieux X; Denys P; Etienne M; Fatton B; Fritel X; Gamé X; Lawrence C; Lenormand L; Lepelletier D; Lucet JC; Marit Ducamp E; Pulcini C; Robain G; Senneville E; de Sèze M; Sotto A; Zahar JR; Caron F; Hermieu JF
    Prog Urol; 2018 Dec; 28(17):943-952. PubMed ID: 30501940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
    Cai T; Mazzoli S; Nesi G; Boddi V; Mondaini N; Bartoletti R
    J Chemother; 2009 Nov; 21(5):535-41. PubMed ID: 19933045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation.
    Palleschi G; Carbone A; Zanello PP; Mele R; Leto A; Fuschi A; Al Salhi Y; Velotti G; Al Rawashdah S; Coppola G; Maurizi A; Maruccia S; Pastore AL
    Arch Ital Urol Androl; 2017 Mar; 89(1):45-50. PubMed ID: 28403598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic prophylaxis in children with relapsing urinary tract infections: review.
    Mangiarotti P; Pizzini C; Fanos V
    J Chemother; 2000 Apr; 12(2):115-23. PubMed ID: 10789549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.
    Carmignani G; De Rose AF; Olivieri L; Salvatori E; Rosignoli MT; Dionisio P
    Urol Int; 2005; 74(4):326-31. PubMed ID: 15897698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
    Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of patient initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study.
    Zhong YH; Fang Y; Zhou JZ; Tang Y; Gong SM; Ding XQ
    J Int Med Res; 2011; 39(6):2335-43. PubMed ID: 22289552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.